Inagaki Y, Unoura M, Urabe T, Ogino H, Terasaki S, Matsushita E, Kaneko S, Morioka T, Furusawa A, Wakabayashi T
First Department of Internal Medicine, Kanazawa University, Japan.
Hepatogastroenterology. 1993 Aug;40(4):316-9.
Recent advances in both diagnosis and treatment of hepatocellular carcinoma (HCC) have improved the prognosis and changed the clinical significance of the subsequently increasing distant metastases. Of 163 patients with HCC, 76 (47%) were treated successfully. The cumulative recurrence rate in these patients was 65% after 3 years, and 82% after 5 years. Six patients with HCC in whom distant metastases were detected after successful treatment of the primary lesion, are reported. Two patients underwent curative surgical resection, and four cases were treated medically, resulting in a 31.9 to 94.3% reduction in tumor size in the CT scan image. Distant metastases without intrahepatic recurrence were diagnosed 10 to 46 months after the treatment of the primary lesions. The sites of the metastases included bone 3; lung 2; and adrenal gland 1. Distant metastases found after successful treatment of the primary lesions are of great clinical significance for the treatment of HCC.
肝细胞癌(HCC)诊断和治疗方面的最新进展改善了预后,并改变了随后不断增加的远处转移的临床意义。在163例HCC患者中,76例(47%)得到成功治疗。这些患者3年后的累积复发率为65%,5年后为82%。本文报告了6例在原发性病变成功治疗后检测到远处转移的HCC患者。2例患者接受了根治性手术切除,4例接受了药物治疗,CT扫描图像显示肿瘤大小缩小了31.9%至94.3%。在原发性病变治疗后10至46个月诊断出无肝内复发的远处转移。转移部位包括骨3处;肺2处;肾上腺1处。原发性病变成功治疗后发现的远处转移对HCC的治疗具有重要的临床意义。